UNIGE document Scientific Article
previous document  unige:111916  next document
add to browser collection
Title

Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration

Authors
Nordström, Dan C
Pavelka, Karel
Hernández, Maria Victoria
Kvien, Tore K
Kristianslund, Eirik Klami
Santos, Maria Jose
Rotar, Žiga
show hidden authors show all authors [1 - 16]
Published in Annals of the Rheumatic Diseases. 2018, vol. 77, no. 9, p. 1276-1282
Abstract To compare the effectiveness of tocilizumab (TCZ) and tumour necrosis factor (TNF) inhibitors (TNFi) as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) after the use of at least one biologic DMARD (bDMARD).
Identifiers
PMID: 29730637
Full text
Article (Published version) (313 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research groups Mécanisme de l'inflammation articulaire (44)
Recherche clinique en rhumatismes inflammatoires (1010)
Citation
(ISO format)
LAUPER, Kim et al. Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration. In: Annals of the Rheumatic Diseases, 2018, vol. 77, n° 9, p. 1276-1282. doi: 10.1136/annrheumdis-2017-212845 https://archive-ouverte.unige.ch/unige:111916

204 hits

0 download

Update

Deposited on : 2018-12-05

Export document
Format :
Citation style :